India plans to increase stockpiles of the anti-influenza drug Tamiflu or its generic version by 10-fold, from one million to 10 million currently, Bloomberg reported, citing Vineet Choudhary, joint secretary, Ministry of Health.
India has also received quotations for supply of the drug from Ranbaxy Laboratories, Cipla, Hetero Drugs and the Indian unit of Roche Holding AG, he said.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/india-boost-drug-stockpile
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/influenza
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
